MADDEN SECURITIES Corp raised its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 4.6% during the second quarter, Holdings Channel.com reports. The firm owned 1,531 shares of the company’s stock after buying an additional 68 shares during the period. MADDEN SECURITIES Corp’s holdings in Procter & Gamble were worth $244,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the business. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble in the first quarter valued at $26,000. Signature Resources Capital Management LLC boosted its stake in Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after buying an additional 72 shares during the last quarter. Quarry LP purchased a new stake in Procter & Gamble in the 1st quarter valued at about $33,000. Mizuho Securities Co. Ltd. increased its stake in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 170 shares during the last quarter. Finally, Quest 10 Wealth Builders Inc. lifted its holdings in shares of Procter & Gamble by 50.3% during the 1st quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company’s stock worth $42,000 after acquiring an additional 82 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Down 1.2%
Shares of NYSE PG opened at $150.47 on Tuesday. The stock has a fifty day moving average price of $155.38 and a 200 day moving average price of $159.84. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a market cap of $352.17 billion, a P/E ratio of 23.11, a P/E/G ratio of 4.02 and a beta of 0.36.
Insider Buying and Selling
In other news, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer owned 319,932 shares in the company, valued at $48,703,248.36. This trade represents a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Andre Schulten sold 4,252 shares of the company’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the transaction, the chief financial officer owned 53,992 shares of the company’s stock, valued at $8,219,202.16. This trade represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 over the last three months. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on PG shares. Berenberg Bank boosted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. BNP Paribas Exane lowered their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a “buy” rating in a report on Wednesday, July 30th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, Barclays lowered their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $173.11.
Read Our Latest Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- How to Short Nasdaq: An Easy-to-Follow Guide
- 3 Exceptional Stocks to Build Long-Term Wealth
- What is the Australian Securities Exchange (ASX)
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.